Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,451-1,475 of 2,022
Not Yet RecruitingNCT06749041

Nor)Clozapine Kinetics and Side Effects in Therapy Resistant Schizophrenia and the Optimal Sampling Time for Therapeutic Drug Monitoring

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Global
Sponsor
GGZ Noord-Holland-Noord
Condition
Schizophrenia
CompletedNCT05322031

The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Italy
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Condition
Schizophrenia
CompletedNCT04038957

A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
TerminatedNCT02088060

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Denmark, Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
CompletedNCT04418466

Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant

This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
Delpor, Inc.
Condition
Schizophrenia
WithdrawnNCT04513132

Targeted Intervention Study of DTMS on Impaired Insight in Early Psychosis

This study exists to see whether the medication DTMS can make care clearer and more responsive. Researchers are trying to understand whether the medication DTMS can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 35 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT05184335

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
CompletedNCT05746455

Motivation Skills Training for Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
RecruitingNCT05580211

Neuromodulation for Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Scion NeuroStim
Condition
Schizophrenia
RecruitingNCT04038840

Imaging Synapses With [11C] UCB-J in the Human Brain

This study exists to improve how brain scans or other body measurements can help identify, measure, or follow care over time. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Davidzon, Guido, M.D.
Condition
Schizophrenia
TerminatedNCT04109950

A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 13 Years to 65 Years
Countries
Bulgaria, Colombia, Croatia, Latvia, Russian Federation, Serbia, Ukraine, United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT06732817

Personalized Dual-target RTMS for Patients with Refractory Schizophrenia

This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Anhui Medical University
Condition
Schizophrenia
CompletedNCT04859504

Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT05814913

Culturally Adapted Psychosocial Interventions for Early Psychosis in a Low-resource Setting

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
RecruitingNCT05159349

Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
RecruitingNCT06729671

A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Ireland
Sponsor
University College Cork
Condition
Schizophrenia
CompletedNCT01602029

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
WithdrawnNCT03994965

The Sub-Sero Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Global
Sponsor
Bjorn H. Ebdrup
Condition
Schizophrenia
CompletedNCT04738123

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Ukraine, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
CompletedNCT04968223

Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social Functioning

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
University of Oldenburg
Condition
Schizophrenia
CompletedNCT05660070

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT06218979

KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Finland
Sponsor
Helsinki University Central Hospital
Condition
Schizophrenia